A former cabinet minister has called pharmaceutical companies to get easy access. NHS data.
Greg ClarkeWho was the business secretary In TheresaSupported a report that says it will happen save lives And give the country finance A multiple pound promotion,
It asks the firms to be able to see anonymous raw details – which will not reveal the personal information of the patients. But the call will prove to be controversial, The data between warnings may fall into the wrong hands.
Mr. Clarke said that Britain “cannot expect to compete on the international platform without the right policies”.
NHS has access to some of the most wide sets of health data in the world with more than 60 million registered patients.
Pharmaceutical firms believe that its sheer shape may allow them to highlight patterns that may be potentially open New type treatment.
Easy NHS data for commercial researchers can add more than £ 10bn more than £ 10bn in the UK economy and create new drugs, according to new research by Lake Consulting, the science charity was commissioned by SCI, which was earlier known as the chemical industry.
SCI Chief Executive Sharon Tod admitted that the idea would provoke “controversy”, but said that it could be “transformational for the UK economy”.
Mr. Clarke, who is also the chairman of the trustee board at SCI, said that the organization knew that “the first limit of our country’s great capacity in life science … with a swatth of world-agronic educational institutions and start-up capacity, the UK needs to be a global leader in the field near the UK.
“However, we cannot expect to compete on the international platform without the right policies. Our research has highlighted meaningful action that can take the future of policy maker UK Life Sciences to feel the future.”
But Jake Moore, a global cyber security advisor to ESET Internet Security, said: “Sharing your health data Pharmaceutical companies Advance medical research has the power to help, but it also worries about privacy and safety risks to be cautious for people.
“Unfortunately, even anonymous data can increase the concerns of privacy because it is risk that your information can be used for commercial advantage without clear advantage to you, or even shared further without your knowledge.
“Ethical issues around consent, transparency and data security means that it is incredibly important who will access your data, how it will be used and what are the safety measures before agreeing to share it. All of whom are often one later for those.
This is not the first time the idea has been suggested. In 2023, the boss of glaxosomithkline called pharmaceutical companies to get easy access to NHS patient data.
Begum Emma Valmasle The then PM Rishi Sunak was called to “more” because he argued that handing over unknown files on millions of Brits would “be more effectively prevented and treated”.
According to NHS England, some NHS data can already be shared with other organizations, if it is “necessary and proportional”.
The Department of Health and Social Care has been contacted for comment.
